FDA 483 - Pharmazell (India) Private Ltd - February 07, 2025

An FDA inspection of Pharmazell (India) Private Ltd's API manufacturing facility in Visakhapatnam revealed significant deficiencies in equipment qualification. The firm failed to conduct proper installation, operational, and performance qualification studies for multiple manufacturing equipment. This indicates a lack of adherence to a written program designed to assure proper equipment performance.